CIBMTR Reporting Implementation Guide - Local Development build (v0.1.6). See the Directory of published versions
<MedicationRequest xmlns="http://hl7.org/fhir">
<id value="MedicationRequest-Etoposide-Example"/>
<meta>
<profile
value="http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-medication-request"/>
<security>
<system
value="http://terminology.cibmtr.org/codesystem/transplant-center"/>
<code value="rc_99999"/>
<display value="99999 My Transplant Center"/>
</security>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="MedicationRequest-Etoposide-Example"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest "MedicationRequest-Etoposide-Example" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-cibmtr-medication-request.html">CIBMTR Medication Request (mcode)</a></p><p style="margin-bottom: 0px">Security Labels: <span title="{http://terminology.cibmtr.org/codesystem/transplant-center http://terminology.cibmtr.org/codesystem/transplant-center}">http://terminology.cibmtr.org/codesystem/transplant-center</span></p></div><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: <a href="Medication-Medication-Etoposide-Example.html">Medication/Medication-Etoposide-Example: etoposide (VEPESID) chemo IVPB</a></p><p><b>subject</b>: <a href="Patient-PatientExample6.html">Patient/PatientExample6</a> ""</p><p><b>authoredOn</b>: 2020-07-21 14:17:00+0000</p><p><b>requester</b>: <span>: unknown</span></p><p><b>reasonCode</b>: Cancer (CMS/HCC) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#363346000 "Malignant neoplastic disease (disorder)"; <a href="http://terminology.hl7.org/5.0.0/CodeSystem-icd10CM.html">International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM)</a>#C80.1 "Malignant (primary) neoplasm, unspecified")</span></p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: 68 mg (100 mg/m2 x 0.68 m2 Treatment plan actual BSA), Intravenous, for 60 Minutes, Every 24 hours, First dose on Tue 11/19/13 at 0000, For 5 doses
Give after CISplatin and mannitol.</p><p><b>timing</b>: Code: Every 24 hours, Starting 2020-07-22 16:58:05+0000, Count 5 times, Duration 60hours, Once per 24 hours, Until 2020-07-22 16:58:05+0000</p><p><b>asNeeded</b>: false</p><p><b>route</b>: Intravenous central route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#418114005)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote></div>
</text>
<status value="active"/>
<intent value="order"/>
<medicationReference>
<reference value="Medication/Medication-Etoposide-Example"/>
<display value="etoposide (VEPESID) chemo IVPB"/>
</medicationReference>
<subject>
<reference value="Patient/PatientExample6"/>
</subject>
<authoredOn value="2020-07-21T14:17:00Z"/>
<requester>
<extension
url="http://hl7.org/fhir/StructureDefinition/data-absent-reason">
<valueCode value="unknown"/>
</extension>
<display value="unknown"/>
</requester>
<reasonCode>
<coding>
<system value="http://snomed.info/sct"/>
<code value="363346000"/>
<display value="Malignant neoplastic disease (disorder)"/>
</coding>
<coding>
<system value="http://hl7.org/fhir/sid/icd-10-cm"/>
<code value="C80.1"/>
<display value="Malignant (primary) neoplasm, unspecified"/>
</coding>
<text value="Cancer (CMS/HCC)"/>
</reasonCode>
<dosageInstruction>
<text
value="68 mg (100 mg/m2 x 0.68 m2 Treatment plan actual BSA), Intravenous, for 60 Minutes, Every 24 hours, First dose on Tue 11/19/13 at 0000, For 5 doses
Give after CISplatin and mannitol."/>
<timing>
<repeat>
<boundsPeriod>
<start value="2020-07-22T16:58:05Z"/>
<end value="2020-07-22T16:58:05Z"/>
</boundsPeriod>
<count value="5"/>
<duration value="60"/>
<durationUnit value="min"/>
<frequency value="1"/>
<period value="24"/>
<periodUnit value="h"/>
</repeat>
<code>
<text value="Every 24 hours"/>
</code>
</timing>
<asNeededBoolean value="false"/>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="418114005"/>
<display value="Intravenous central route (qualifier value)"/>
</coding>
</route>
<doseAndRate>
<type>
<text value="admin-amount"/>
</type>
<doseQuantity>
<value value="68"/>
<unit value="milligram"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</doseQuantity>
</doseAndRate>
<doseAndRate>
<type>
<text value="ordered"/>
</type>
<doseQuantity>
<value value="100"/>
<unit value="milligram per square meter"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg/m2"/>
</doseQuantity>
</doseAndRate>
</dosageInstruction>
</MedicationRequest>
IG © 2020+ The Medical College of Wisconsin, Inc. and the National Marrow Donor Program
Package nmdp.fhir.cibmtr-reporting#0.1.6 based on FHIR 4.0.1. Generated 2023-05-05
Links: Table of Contents |
QA Report
HL7®, and FHIR® are the registered trademarks of Health Level Seven International
and their use of these trademarks does not constitute an endorsement by HL7.